Core Concepts
Mailing self-sampling kits for high-risk HPV is a cost-effective strategy to increase cervical cancer screening uptake.
Abstract
The content discusses the cost-effectiveness of mailing self-sampling kits for high-risk human papillomavirus (HPV) to increase cervical cancer screening uptake. The study analyzed almost 20,000 women in a randomized trial, highlighting the effectiveness of this strategy, especially in women aged 50-64 years and those recently overdue for screening. The authors emphasize the importance of this outreach strategy in US healthcare systems, particularly in overcoming screening barriers among underscreened women. The study's economic evaluation and results on screening uptake, positive test results, and treatment rates provide valuable insights into the benefits of home-based HPV screening.
Stats
Mailing self-sampling kits for high-risk HPV is a cost-effective means of increasing screening uptake.
Screening uptake was higher in the intervention group than control participants, at 26.3% vs 17.4%, respectively.
The incremental cost-effectiveness ratio for increased screening uptake ranged from $85.84 to $146.29.
Home-based screening achieved a 90% probability of cost-effectiveness at different willingness-to-pay thresholds.
Quotes
"These results support mailing HPV kits as an efficient outreach strategy for increasing screening rates in US health care systems."